论文部分内容阅读
目的:探讨肝癌患者的肝动脉化学栓塞,术后副作用和并发症原因及影响因素。方法:对100例原发或继发肝脏恶性肿瘤进行180次肝动脉化学栓塞。结果:术后出现发热(87%),肝区疼痛或原肝区疼痛加重(70%),恶心呕吐(88%),术后肝功能childC级15例(7.4%),术后并发症包括肝脓肿1例,肝肾综合征1例。结论:对晚期不能切除肝癌患者行TACE时,应严格掌握适应证,选择合理的个体化治疗方案。
Objective: To investigate the causes of hepatic arterial chemoembolization, postoperative side effects and complications and their influencing factors in patients with liver cancer. Methods: One hundred cases of primary or secondary hepatic malignancies were subjected to hepatic artery chemoembolization 180 times. Results: Postoperative fever (87%), pain in the liver area or aggravation of the original liver area (70%), nausea and vomiting (88%), postoperative liver function in 15 cases of childC (7.4%), postoperative complications included 1 case of liver abscess, 1 case of hepatorenal syndrome. Conclusion: TACE for patients with advanced liver cancer can not be removed, the indications should be strictly controlled, select a reasonable individualized treatment options.